Vaxcyte, Inc.
PCVX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Vaxcyte, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 8 filings
- 4 insiders, $3.68M in total
- Insiders trading
- 4
- Net value
- −$3.68M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Vaxcyte, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Pickering Grant | CHIEF EXECUTIVE OFFICER | 429,902 | Sep 9, 2026 | 8 |
| Guggenhime Andrew | PRESIDENT AND CFO | 95,316 | Sep 9, 2026 | 8 |
| Dhaliwal Harpreet S. | Chief Technical Ops Officer | 68,085 | Sep 9, 2026 | 6 |
| Cowan Elvia | SVP, Finance & CAO | 27,860 | Sep 9, 2026 | 7 |
| Wassil Jim | EVP, Chief Scientific Ofc, COO | 145,435 | Sep 9, 2026 | 9 |
| Jodar Luis | Chief Medical Officer | 52,632 | Sep 9, 2026 | 1 |
| Markels John | Director | – | Jul 16, 2026 | 1 |
| Slaoui Moncef | Director | – | Jun 23, 2026 | 1 |
| Drapeau Anne S | Director | 12,481 | Jun 16, 2026 | 1 |
| Brandicourt Olivier | Director | 4,699 | Jun 16, 2026 | 2 |
| Lukatch Heath | Director | 19,481 | Jun 16, 2026 | 1 |
| Gilbert Halley E | Director | 12,481 | Jun 16, 2026 | 1 |
| Paya Carlos V | Director | 6,856 | Jun 16, 2026 | 1 |
| Furey John | Director | 5,306 | Jun 16, 2026 | 1 |
| Loxam Teri | Director | 12,481 | Jun 16, 2026 | 1 |
| Lee Jacks | Director | 6,856 | Jun 16, 2026 | 1 |
| Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | 41,620 | Mar 7, 2025 | 0 |
| Hirth Peter | Director | 7,175 | Jun 10, 2024 | 0 |
| Kamarck Michael E. | Director | 5,625 | Jun 15, 2023 | 0 |
| Sauer Paul | SVP Process Dev, Manufacturing | 13,822 | Jan 4, 2023 | 0 |
| Fairman Jeff | VP, Research | 286,227Indirect | Jan 4, 2023 | 0 |
| Wright-Mitchell Jane | General Counsel | 3,125 | Aug 18, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 24, 2022 (view filing) | May 20 | 4 days | Fairman JeffVP, Research | SSale | −4.11K | $25.50 | −$104.9K | −1.3%321.2K after | |
| May 20, 2022 (view filing) | May 18 | 2 days | Guggenhime AndrewPresident and CFO | SSale | −3.10K | $24.44 | −$75.8K | −6.8%42.2K after | 2 lots |
| May 18, 2022 (view filing) | May 16 | 2 days | Pickering GrantChief Executive Officer | SSale | −11.0K | $23.91 | −$263.0K | −1.5%703.9K after | 2 lots |
| May 9, 2022 (view filing) | May 5 | 4 days | Fairman JeffVP, Research | SSale | −888 | $25.80 | −$22.9K | −0.3%325.3K after | |
| Apr 26, 2022 (view filing) | Apr 22 | 4 days | Sauer PaulSVP Process Dev, Manufacturing | SSale | −3.00K | $25.00 | −$75.0K | −10.7%25.1K after | |
| Apr 20, 2022 (view filing) | Apr 18 | 2 days | Wassil JimChief Operating Officer | SSale | −2.80K | $23.98 | −$67.1K | −6.1%42.9K after | |
| Apr 20, 2022 (view filing) | Apr 18 | 2 days | Guggenhime AndrewPresident and CFO | SSale | −3.10K | $24.05 | −$74.6K | −7.1%40.6K after | |
| Apr 20, 2022 (view filing) | Apr 18 | 2 days | Pickering GrantChief Executive Officer | SSale | −11.0K | $23.98 | −$263.8K | −1.5%703.9K after | |
| Apr 7, 2022 (view filing) | Apr 5 | 2 days | Fairman JeffVP, Research | SSale | −5.00K | $25.59 | −$128.0K | −1.5%326.2K after | |
| Mar 24, 2022 (view filing) | Mar 22 | 2 days | Sauer PaulSVP Process Dev, Manufacturing | SSale | −3.00K | $25.00 | −$75.0K | −9.6%28.1K after | |
| Mar 23, 2022 (view filing) | Mar 21-22 | 2 days | Pickering GrantChief Executive Officer | SSale | −22.0K | $24.83 | −$546.2K | −3.0%703.9K after | 3 lots |
| Mar 22, 2022 (view filing) | Mar 18 | 4 days | Guggenhime AndrewPresident and CFO | SSale | −3.10K | $26.13 | −$81.0K | −7.1%40.6K after | |
| Mar 15, 2022 (view filing) | Mar 11 | 4 days | Fairman JeffVP, Research | SSale | −10.0K | $25.50 | −$255.0K | −2.9%331.2K after | |
| Mar 14, 2022 (view filing) | Mar 10 | 4 days | Sauer PaulSVP Process Dev, Manufacturing | SSale | −6.00K | $25.00 | −$150.0K | −16.2%31.1K after | |
| Mar 3, 2022 (view filing) | Mar 1 | 2 days | Guggenhime AndrewPresident and CFO | SSale | −6.20K | $24.00 | −$148.8K | −66.5%3.13K after | |
| Feb 28, 2022 (view filing) | Feb 24 | 4 days | Wassil JimChief Operating Officer | SSale | −10.0K | $22.00 | −$220.0K | −35.8%17.9K after | |
| Dec 30, 2021 (view filing) | Dec 29 | 1 day | Sauer PaulSVP Process Dev, Manufacturing | SSale | −6.00K | $25.00 | −$150.0K | −18.1%27.1K after | |
| Dec 28, 2021 (view filing) | Dec 27 | 1 day | Fairman JeffVP, Research | SSale | −4.75K | $23.60 | −$112.1K | −43.5%6.16K after | 2 lots |
| Dec 28, 2021 (view filing) | Dec 23 | 5 days | Guggenhime AndrewPresident and CFO | SSale | −3.10K | $24.00 | −$74.4K | −49.8%3.13K after | |
| Dec 20, 2021 (view filing) | Dec 16 | 4 days | Fairman JeffVP, Research | SSale | −4.62K | $22.50 | −$103.9K | −42.9%6.16K after | |
| Dec 13, 2021 (view filing) | Dec 9 | 4 days | Fairman JeffVP, Research | SSale | −131 | $22.50 | −$2.95K | −2.1%6.16K after | |
| Nov 23, 2021 (view filing) | Nov 19 | 4 days | Pickering GrantChief Executive Officer | SSale | −15.0K | $23.45 | −$351.7K | −2.5%580.3K after | 2 lots |
| Nov 22, 2021 (view filing) | Nov 18 | 4 days | Guggenhime AndrewPresident and CFO | SSale | −3.10K | $24.53 | −$76.0K | −49.8%3.13K after | 2 lots |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Sauer PaulSVP Process Dev, Manufacturing | SSale | −3.00K | $25.00 | −$75.0K | −8.3%33.1K after | |
| Oct 28, 2021 (view filing) | Oct 26 | 2 days | Fairman JeffVP, Research | SSale | −4.75K | $22.69 | −$107.8K | −48.0%5.14K after | |
| Oct 22, 2021 (view filing) | Oct 20 | 2 days | Pickering GrantChief Executive Officer | SSale | −15.0K | $22.58 | −$338.8K | −2.5%580.3K after | 2 lots |
| Sep 29, 2021 (view filing) | Sep 27 | 2 days | Fairman JeffVP, Research | SSale | −4.75K | $26.17 | −$124.3K | −48.0%5.14K after | 2 lots |
| Sep 24, 2021 (view filing) | Sep 22 | 2 days | Sauer PaulSVP Process Dev, Manufacturing | SSale | −5.31K | $25.20 | −$133.7K | −12.8%36.1K after | |
| Sep 23, 2021 (view filing) | Sep 21-22 | 2 days | Pickering GrantChief Executive Officer | SSale | −15.0K | $25.21 | −$378.2K | −2.5%580.3K after | 3 lots |
| Aug 30, 2021 (view filing) | Aug 26 | 4 days | Fairman JeffVP, Research | SSale | −4.75K | $25.38 | −$120.5K | −48.0%5.14K after | 2 lots |
| Aug 25, 2021 (view filing) | Aug 23 | 2 days | Pickering GrantChief Executive Officer | SSale | −13.7K | $22.73 | −$310.7K | −2.3%580.3K after | 2 lots |
| Aug 20, 2021 (view filing) | Aug 19 | 1 day | Pickering GrantChief Executive Officer | SSale | −1.33K | $22.40 | −$29.8K | −0.2%580.3K after | |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Wright-Mitchell JaneGeneral Counsel | SSale | −2.50K | $26.00 | −$65.0K | −44.4%3.13K after | |
| Aug 16, 2021 (view filing) | Aug 12 | 4 days | Wright-Mitchell JaneGeneral Counsel | SSale | −10.0K | $26.00 | −$260.0K | −76.2%3.13K after | |
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Fairman JeffVP, Research | SSale | −4.75K | $22.70 | −$107.8K | −48.0%5.14K after | |
| Jul 22, 2021 (view filing) | Jul 20 | 2 days | Pickering GrantChief Executive Officer | SSale | −15.0K | $22.85 | −$342.8K | −2.5%580.3K after |